VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESGO 2021 | Chemotherapy vs. palliative care for patients with ovarian cancer

Nicoletta Colombo, MD, PhD, European Institute of Oncology, Milan, Italy & University of Milan-Bicocca, Milan, Italy, discusses how to make treatment decisions with patients who have terminal ovarian cancer. The decision over whether to undergo a chemotherapy regimen, which typically has low success rates in these patients, or to offer palliative care instead relies on a lot of factors and can be a difficult decision for both clinicians and patients. Clinical trials can offer improved progression free survival or quality of life for these patients, so should also be considered when deciding on treatment. A key challenge for clinicians is how to communicate about end-of-life issues with patients and their families.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter